Calithera Biosciences, Inc. | 3 | 0001395064-22-000058

SEC Filing Details

Document Details

Form

Filing Date

Apr 21, 2022

Document Date

Oct 18, 2021

Form Description

Initial filing by director officer or owner of more than ten percent.

Filing Group

3,4,5

Company

Calithera Biosciences, Inc.

Issuer

Calithera Biosciences, Inc.

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

Investor & Media Contact

Stephanie Wong
Chief Financial Officer

1.650.870.1063
ir@Calithera.com

Investor Tools